Swabs are made of absorbent material, which imparts medicinal properties to it. Swab is part of surgery and medicine and it is used in surgical procedures, injuries, at pre injection site and in diagnostic kits to obtain sample. The major role of swab is wound cleansing and disinfection. The antiseptics used in swab are iodine, cetrimide and disinfectant such as alcohol.
Increasing prevalence of accidents and falls cause’s injuries, which is expected to increase surgical procedures, in turn driving swab market growth. According to World Health Organization (WHO) factsheet in 2018, annually there are around 37.3 million falls, which require medical attention, whereas an estimated 646,000 individuals die annually from falls globally. Moreover, increasing prevalence of cardiovascular disease is expected to propel treatment via surgery, which is expected to boost the market growth.
Get a PDF Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2513
According to the, World Health Organization (WHO) published in 2009, around 3.8 million men and 4.4 million women die annually from coronary heart disease worldwide. Moreover, according to the same source, the mortality for age between 15 to 59 years, was around 1,332, 000 and for above 60 years of age, it was around 5,825, 000.
Key players in the market are focused on research and development in order to develop novel products to address the critical unmet needs of patients. For instance, in November 2018, Meridian Bioscience Inc. received approval from Food and Drug Administration (FDA) for Alethia CMV Assay Test System, which is used in detection of cytomegalovirus in newborn babies under age of 21 days by using saliva swab.
Moreover, increase in geriatric population is expected to rise incidences of chronic diseases, which in turn is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in May 2016, around 19% of the population in the U.S. is projected to fall in the geriatric category by 2030. Moreover, in the U.S., around 40 million individuals age above 65 years are affected by cardio vascular diseases.
The government initiatives for free diagnostic test is expected to boost the market growth. For instance, in union budget 2014 -15, the Government of India announced free drug service and free diagnostic test initiative under the National Health Mission (NHM). In July 2015, the Ministry of Health and Family Welfare (MoHFW) formulated guidelines and shared it to states and union territories.
Increasing geriatric population susceptible to cardiovascular disease in this region is expected to bolster the market growth over the forecast period. According to the American Heart Association, December 2015, an estimated 85.6 million Americans suffers from some form of cardiovascular disease and nearly 50% of African and America adults are diagnosed with cardiovascular disease in which women comprised around 48% and men around 46%
Moreover, key players in the market are focused on receiving the U.S. Food and Drug Administration (FDA) approval for novel products in diagnostic tools. For instance, in April 2018, Parsagen Diagnostic Inc., received the U.S. Food and Drug Administration (FDA) approval for PartoSure test, which consist of sterile flocked swab, lateral flow test strip, and vial with extraction solvent.
Click To Continue Reading On Swab Market
Major players operating in the global swab market include Puritan Medical Products, Copan Diagnostics, Inc., Sarstedt AG & Co. KG, FI Medical MWE, Cleancross Co.,LTD., AdvaCare Systems, GPC Medical Ltd., Elmex Controls Pvt Ltd., and Citotest Labware Manufacturing Co., Ltd.